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Background: Domestication has shaped the horse and lead to a group of many different types. Some have been
under strong human selection while others developed in close relationship with nature. The aim of our study was
to perform next generation sequencing of breed and non-breed horses to provide an insight into genetic influences
on selective forces.
Results: Whole genome sequencing of five horses of four different populations revealed 10,193,421 single nucleotide
polymorphisms (SNPs) and 1,361,948 insertion/deletion polymorphisms (indels). In comparison to horse variant
databases and previous reports, we were able to identify 3,394,883 novel SNPs and 868,525 novel indels. We analyzed
the distribution of individual variants and found significant enrichment of private mutations in coding regions of genes
involved in primary metabolic processes, anatomical structures, morphogenesis and cellular components in non-breed
horses and in contrast to that private mutations in genes affecting cell communication, lipid metabolic process,
neurological system process, muscle contraction, ion transport, developmental processes of the nervous system and
ectoderm in breed horses.
Conclusions: Our next generation sequencing data constitute an important first step for the characterization of
non-breed in comparison to breed horses and provide a large number of novel variants for future analyses. Functional
annotations suggest specific variants that could play a role for the characterization of breed or non-breed horses.Background
The process of domestication has shaped the modern
horse population and lead to an immense group of differ-
ent types of breeds [1,2]. Various environmental as well as
artificial factors affected the population structure and lead
to the formation of more than 400 horse breeds today
[2,3]. In order to create horses with a characteristic uni-
form appearance and function, some breeds have espe-
cially been under strong directional selection to a special
breeding goal while other populations still underlie a
greater natural selection and have kept their original prop-
erties to survive under harsh environment [2,4]. Despite
human influences, the Duelmener horse as well as the* Correspondence: ottmar.distl@tiho-hannover.de
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unless otherwise stated.Sorraia developed under quite natural circumstances as
they are generally kept under free range conditions with-
out specific human care for health. They show typical
primitive markings and a robust constitution for the sur-
vival under harsh conditions [5-7]. Those horses which are
less subjected to a breeding goal but to the preservation
of this specific population can be grouped as non-breed
horses [2]. These non-breeds developmentally lie in-
between the highly selected modern horse breeds and the
Przewalski population which falls outside of the monophy-
letic group of domestic horses and represents the last sur-
vivor of wild horses [8]. In contrast to that the Hanoverian
as well as the Arabian, one of the oldest recognized do-
mestic breeds, have been subject to close breeding and in-
tense human selection for their high ability in function
and performance [9,10]. A comparative whole genome se-
quence analysis with the genomes of five modern domesticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and suggested a continuous selection on the immune
system and olfaction throughout horse evolution. Other
genomic regions showed low levels of genetic variation
compared to the Przewalski horse and were suggested
to be potentially selected early during domestication
[8]. Further specific modern domestic horse variants
have been investigated by next generation sequencing of
a Quarter horse mare that provided 2.8 million novel
SNPs, 193 thousand indels and 282 CNVs and revealed
an enrichment of biological processes involved in sen-
sory perception, signal transduction, immunity and defense
pathways [11]. The aim of this study was to investigate
the influence of human selection on domestic horses by
comparative analysis of non-breed to breed horses. Next
generation sequencing was performed to characterize
five horses of two different breeds and two different
non-breeds representing the highly diverse horse popu-
lation by the detection of novel genetic variations. The
results show that the process of domestication as well
as further artificial selection for specific breeding aims
has influenced the development of specific biological
processes in horse breeds.
Results
Sequence analysis and variant detection
Whole genome sequencing was performed in two
Hanoverians and one Arabian representing breed horses
and one Duelmener and Sorraia representing non-breed
horses using the Illumina HiSeq2000 (Illumina, San Diego,
CA). Each horse was run on one lane except one of the
Hanoverians (Hanoverian 1) which was run on two lanes
due to its importance for the Hanoverian breed. After
passing filters, reads were trimmed and aligned to the
reference horse genome derived from the Thoroughbred
mare Twilight and its half-brother Bravo (EquCab2.70,
Additional file 1A) [12]. The alignment resulted in a mean
coverage of 14.02X for the Duelmener, 12.21X for the Sor-
raia, 13.37X for the Arabian, 10.97X for Hanoverian 2 and
a higher mean coverage of 25.38X for Hanoverian 1 due
to its run on two lanes (Additional file 1B). In total 67.38%
of the reference genome showed at least 10X sequence
coverage in the Duelmener, 52.87% in the Sorraia, 62.54%
in the Arabian and 40.86% in Hanoverian 2. The two lane
run for Hanoverian 1 increased the average number of
reads and resulted in a 10X sequence coverage in 96.65 of
the reference genome. The aligned sequence was further
processed for variant detection and revealed 5,391,494
SNPs in the Duelmener, 5,075,637 in the Sorraia, 5,156,659
in the Arabian, 5,264,058 in Hanoverian 1 and 5,032,162 in
Hanoverian 2. On the whole, 1,712,330 SNPs were shared
by all five horses (Additional file 1C). All horses had
551,444 indels in common, while the individual number
of indels was at 889,106-935,333. In total our analysisrevealed 10,193,421 SNPs and 1,361,948 indels. Heterozy-
gosity was 0.317 SNPs/site in the Duelmener, 0.300 SNPs/
site in the Arabian, 0.342 SNPs/site in Hanoverian 1, 0.309
SNPs/site in Hanoverian 2 and 0.244 SNPs/site in the
Sorraia. Considering the distribution of variants identified
on the individual chromosomes of non-breed and breed
horses, these groups showed an almost identical number
of variants per chromosome (Additional file 2). The high-
est number of variants could be detected on chromosome
(ECA) 1. Nevertheless, with regard to the chromosomal
enrichment of detected variants accounted by dividing the
number of variants by the length of the chromosomes
(bp), we could show that especially ECA12 and ECA20
were over the threshold of the whole genome enrichment
(Additional file 3). On the whole, 19 chromosomes of the
analyzed 32 chromosomes and the mitochondrial DNA
exceeded the threshold of the average number of variants
per base pair of the whole genome.
Comparison with Equine SNP50 genotyping beadchip and
public databases
Comparative analyses of the detected SNPs by next gener-
ation sequencing with Equine SNP50 genotyping beadchip
data in the Arabian and the two Hanoverian showed that
the variant detection was reliable for these data. In total,
95.92% of the SNPs from beadchip analysis could be con-
firmed by next generation sequencing for the Arabian and
97.42% for the Hanoverian (Hanoverian 2) run on one
lane (Figure 1). The Hanoverian which was run on two
lanes (Hanoverian 1) even showed a concordance with
beadchip data of 99.13%. Only 0.51% of the SNPs were dif-
ferent in genotype and 0.36% was not detected by next
generation sequencing.
Further comparison was performed with SNP and
indel data from open access data bases with the present
variant detection results. A total of 907,776 SNPs of our
analysis showed an overlap with dbSNP (dbSNP, ftp://
ftp.ncbi.nih.gov/snp/organisms/horse_9796/chr_rpts/),
907,864 SNPs with Ensembl (ftp://ftp.ensembl.org/pub/re-
lease-73/variation/gvf/equus_caballus/ Equus_caballus.gvf.
gz) and 910,822 SNPs with Broad Institute (http://www.
broadinstitute.org/ftp/distribution/horse_snp_release/v2/)
data, while 9,281,631 SNPs could not be retrieved from
these databases (Figure 2). In comparison with NGS data
from previous studies in a Quarter horse with a minimum
read depth coverage of 10X [11] and in five domestic
horses (Arabian, Icelandic, Norwegian fjord, Standard-
bred, Thoroughbred, 7.9-21.1X), one Przewalski (9.6X)
and one donkey (16X) [8], we found 1,782,560 shared
SNPs, 268,966 SNPs known from the Quarter horse data
and 4,697,675 exclusively overlapping with SNPs derived
from the five domestic horses, Przewalski or donkey
(Figure 3). In total 3,444,220 SNPs could not be found in
these published whole genome sequence data. With regard
Figure 1 Comparison between SNPChip and NGS data. All three horses genotyped by SNPchip and NGS show a low frequency of SNPs
different in genotype or not detected by NGS.
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lyses we detected 3,394,883 novel SNPs. Comparative
analyses of our indel data with previous studies revealed
236 indels shared in all projects, 18,800 indels known
from the Quarter horse and 474,387 indels overlappedFigure 2 Comparison of SNP data from present study with known SN
Ensembl and Broad Institute databases and the number of novel SNPs fromthe study with the five domestic horses, a Przewalski
and a donkey [8]. In total 868,525 indels were exclusive
in our data (Figure 4). With regard to the mutation type
a huge number of 15,012 novel non-synonymous SNPs
were predicted as well as SNPs affecting splice sites,Ps in various databases. The number of common SNPs with dbSNP,
present analysis is shown.
Figure 3 Comparison of SNP data from present study with known SNPs in previous NGS analyses. The number of common SNPs with
Orlando et al. and Doan et al. and the number of novel SNPs from present analysis is shown.
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novel indels in our analysis were proposed to have dif-
ferent effects like codon deletions, codon insertions and
a large number of 4,916 frame shifts as well as four exon
deletions could be found.
Functional annotation and characterization
We investigated the variants detected in our analysis for
their effects on basis of the variant annotation and effect
prediction tool SNPEff [13] and their distribution across
breed and non-breed horses. Most of the variants revealed
one or two predicted SNPEff-effects. Regarding the private
SNPs that could only be found in one of the compared
horses or groups, non-breed horses showed a larger num-
ber of effects by private SNPs in intergenic as well as genic
regions in comparison with breed horses (Table 2). A total
of 810,687 effects could be detected affected by private
SNPs in the Duelmener and 824,072 effects in the Sorraia.Figure 4 Comparison of indel data from present study with known SN
Orlando et al. and Doan et al. and the number of novel SNPs from presentThe Arabians showed 737,324 effects while the Hanoverian
horses revealed an even lower number of effects (316,464)
as a result of a reduced number of private SNPs due to the
analysis of two horses. With regard to specific effects,
9,507 non-synonymous SNPs were predicted to be shared
by all horses while 3,053 private SNPs in the Duelmener,
2,367 private SNPs in the Sorraia, 2,191 private SNPs in
the Arabian and 878 private SNPs in the Hanoverian
horses. Nevertheless, functional classification analysis
of the distribution of genes affected by private non-
synonymous SNPs did not reveal any significant differences
in these groups (Additional file 5). Other effects like splice
site donors, splice site acceptors, start and stop codon
changes were also predicted for shared and private vari-
ants. We further investigated the loss of the stop codons
possibly affected by private SNPs and identified the genes
ATP13A4 (probable cation-transporting ATPase 13A4) in
the Duelmener, ENSECAG00000000628 (TRBV6-4, T cellPs in previous NGS analyses. The number of common indels with
analysis is shown.










Orlando et al. [8]
Common variants




Exon 8056 679 678 693 4650 1974 2920
Non-synonymous
coding
43043 3014 3002 3026 25200 12759 15007
Non-synonymous
start
10 1 1 1 3 3 5
Start lost 48 4 4 4 30 19 15
Stop gained 383 16 16 16 185 81 182
Stop lost 29 6 6 6 20 5 8
Synonymous coding 52965 4367 4355 4368 34360 16144 15962
Synonymous start 1 0 0 0 0 0 1




133 - - - 31 0 102
Codon change plus
codon insertion
248 - - - 62 0 186
Codon deletion 201 - - - 55 1 145
Codon insertion 178 - - - 39 2 137
Exon 828 - - - 284 26 518
Exon deleted 4 - - - 0 0 4
Frameshift 7360 - - - 1903 541 4916
Start lost 7 - - - 2 0 5
Stop gained 25 - - - 6 0 19
The total number of SNPs and indels per SNPEff term detected in five horses and their concordance with dbSNP, Broad Institute and Ensembl data as well as data
published by Orlando et al. [8] and Doan et al. [11] are shown.
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(OR2A2, olfactory receptor, family 2, subfamily A, member
2) in the Sorraia and RTDR1 (Rhabdoid tumor deletion re-
gion gene 1) and ENSECAG00000008382 in the Hanove-
rians but no loss of stop codons in the Arabian (Additional
file 6). All private losses of stop mutations were heterozy-
gous for the respective individuals. Analyses of the indels
revealed 629,686 effects predicted for shared variants in
the five horses. Especially codon changes, splice site mo-
difications, frameshift mutations as well as one exon dele-
tion became apparent in the detection of private indels
(Additional file 6). The heterozygous 21 bp deletion de-
tected exclusively in the Duelmener was predicted to affect
the gene CNDP2 (dipeptidase 2, metallopeptidase M20
family) (Additional file 7). Further investigation of the
predicted codon changes due to private indels revealed
an increased occurrence of genes involved in immune
system processes in breed horses (22.6%) in comparison
to non-breed horses (6.7%, Additional file 7 and 8). The
mean heterozygosity in immunity related regions could
be shown to be considerably high in breed horses (0.30-
0.33) in contrast to the Duelmener (0.24) and Sorraia(0.09). We performed an enrichment analysis for coding
and regulative regions affected by SNPs for breed and
non-breed horses. An analysis of coding regions in non-
breed horses revealed an enrichment of genes involved in
primary metabolic processes as well as genes involved in
anatomical structures, morphogenesis and cellular compo-
nents (Figure 5, Additional file 8). Breed horses showed an
enrichment of genes in coding regions involved in cell
communication, lipid metabolic process, neurological sys-
tem process, muscle contraction, ion transport and devel-
opmental processes of the nervous system and ectoderm.
Regulative regions with private non-breed SNPs were
enriched with genes affecting proteolysis and fatty acid
metabolic processes, while breed horses showed an en-
richment of genes in system processes, exocytosis, devel-
opmental processes, cell communication, transport and
sensory perception of sound (Additional file 9).
Further investigation of known variants revealed a con-
fident detection of the basic coat color black/chestnut and
bay phenotypes (Table 3) [14]. Analysis of coat color geno-
types associated with a disease did not reveal any muta-
tions. Further search for disease traits confirmed that the
Table 2 Number of effects by private and shared SNPs detected by next generation sequencing of five horses
SNPEff terms by type Shared (all 5 horses) Duelmener Sorraia Arabian Hanoverian (two horses)
Downstream 89229 43289 34418 31295 13056
Exon 1728 694 494 48 192
Intergenic 1313808 711015 549696 487818 207619
Intron 451550 256400 199575 180419 79926
Non-synonymous coding 9507 3053 2367 2191 878
Non-synonymous start 7 0 0 0 0
Splice site acceptor 159 15 10 11 3
Splice site donor 260 23 19 16 7
Start gained 159 57 43 17 10
Start lost 15 0 0 0 0
Stop gained 48 36 28 29 16
Stop lost 8 1 2 0 2
Synonymous coding 8138 3883 3030 2686 1198
Synonymous start 1 0 0 0 0
Synonymous stop 1 4 4 1 1
Upstream 113982 45203 36447 32191 13289
3‘UTR 1240 607 488 437 191
5‘UTR 1682 243 178 165 76
total 1584011 810687 824072 737324 316464
The presented results are classified by SNPEff terms for each breed.
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which is associated with genetic carriers for cerebellar abio-
trophy [15] (Table 4). Performance trait analysis further
characterized the different horse breeds. The Duelmener,
Sorraia and Arabian showed a T/T genotype for the poly-
morphism BIEC2-808543 which was proposed to affect the
ligand dependent nuclear receptor corepressor-like (LCORL)
as the main regulator for body size in horses [16-18]. The
larger sized Hanoverians had a heterozygous C/T genotype
(Table 5). Five SNPs affecting racing performance were also
investigated and suggested the Arabian and Hanoverians to
be the horses with good stamina in long distances. Espe-
cially one Hanoverian was heterozygous for all racing per-
formance traits. The Duelmener showed a heterozygous
genotype for the g.66493737C/T mutation in the myostatin
gene (MSTN) which is associated with middle distance ra-
cing ability and two further mutations associated with good
racing performance [19]. In contrast to the Duelmener, the
Sorraia showed the C/C genotype in theMSTN gene which
can be found in fast horses in short distances.
Discussion and conclusion
The objective of this study was to give an insight into the
diversity of the horse population by comparative analysis
of breed to non-breed horses using next generation se-
quencing. Both groups revealed a large number of poten-
tial novel SNPs and indels that could not be found in any
horse database. Comparative analyses with BeadChip dataand known variants causing coat color and disease pheno-
types suggested that our sequencing data with a mean
coverage of 11-25X provide a reliable basis for variant de-
tection despite possible limitations due to lower sequence
coverage in specific regions and errors in the reference
genome that might simulate genetic variants [11]. Variant
effect prediction by SNPEff was probably under the same
limitations regarding the genome build EquCab2.70, but
the use of this tool on basis of pre-build databases has
been successfully applied for re-sequencing studies in
horses and other mammals so far [41-43].
Our next generation sequencing data of one or two
horses of different populations each gives us a broad
idea of how diverse domestic horses really are. The ana-
lyzed horses are derived from different developmental
groups of the horse population representing one of the
oldest and strongly selected breeds (Arabian), one highly
selected sport horse breed (Hanoverian) and two popu-
lations from different geographic backgrounds that under-
lie a strong natural selection (Duelmener, Sorraia). These
horses were chosen as characteristic representatives for
their population in order to reflect distinctive attributes of
selectively bred horses in comparison to horse populations
not bred for specific purposes. The use of the term “breed”
has been discussed very differently. The main point for the
differentiation of non-breed and breed was the question if
the population was subject to controlled breeding and
husbandry imposed by humans [44]. We suggest that the
Figure 5 Enrichment analysis of private variants affecting coding regions of breed and non-breed horses. Significantly enriched gene
ontology (GO) terms common or specific for breed and non-breed horses are shown.
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those strong human influences and should therefore be
grouped as non-breed.
In comparison to breed horses we were able to detect
a larger number of private SNPs in non-breed horses.
Nevertheless, despite the lower number of private SNPs,
breed horses showed a large number of private indels with
codon changing effects in genes involved in immune sys-
tem processes. Some of these genes play a role in the cell
surface receptor linked signal transduction (olfactory re-
ceptor gene 56A4, OR56A4), others affect antigen process-
ing and presentation (SRSF protein kinase 2, SRPK2;
CALPAIN-8, CAPN8) [45-47]. The heterozygosity of vari-
ants in these immunity-related regions could be shown to
be high in comparison to the detected variants of non-
breed horses. Comparative analysis of modern domestic
horses with a Przewalski horse suggested that regions of
significant reduction of the genetic diversity in modern
horses correspond to specifically selected loci while re-
gions of high densities of mutations give evidence of
continuous selection as it could be shown in immunity-
related and olfactory genes in modern horses [8]. Our data
confirm this assumption which presumably reflects the
importance for variability of the immune system especiallyin breed horses [48]. In contrast to that, the investigated
non-breed horses showed an enrichment of private muta-
tions in genes affecting metabolism, anatomical structures,
morphogenesis and cellular components which might give
us an idea of the genetic background of their characteris-
tics. We can only speculate if private mutations detected in
pheromone and odorant binding vomeronasal receptor 1
(EQUCABV1R928) or in the probable cation-transporting
ATPase 13A4 (ATP13A4) as well as ATPase, class VI, type
11B (ATP11B), that play a role for chemoreception, might
be involved in non-breed specific abilities. Nevertheless,
despite similar characteristics to the Duelmener, the het-
erozygosity was inferior in the Sorraia horse in comparison
with all other horses. We assume that this result is consist-
ent with previous assumption that the Sorraia population
shows losses in the level of heterozygosity as it has under-
gone a genetic bottleneck [49].
In conclusion, our analysis is provided to give an insight
into possible interrelations between populations and spe-
cific characteristics. We suggest that this data of five
horses form a basis for future verification studies in a lar-
ger number of horses that will build on these results and
help to elucidate specific genetic features by further elim-
ination of individual variants and by increased sequence
Table 3 Investigation of known variants affecting coat colors and color phenotypes associated with disease traits











Chestnut/black 3 36,259,552 MC1R C/T substitution: Ser/Phe C/C T/T C/C T/T C/T [14]
Chestnut 3 36,259,554 MC1R G/A substitution: Asp/Asn G/G G/G G/G G/G G/G [20]
Bay/black 22 25,168,579 ASIP 11 bp deletion: frameshift ref/ref ref/ins ref/ref ref/ref ref/ins [14]
Grey 25 6,575,277 STX17 4.6 kb duplication Not detected Not detected Not detected Not detected Not detected [21]
Cream 21 30,666,626 SLC45A2 11 bp deletion: frameshift Not detected Not detected Not detected Not detected Not detected [22]
Champagne 14 26,701,092 SLC36A1 C/G substitution: Thr/Arg G/G G/G G/G G/G G/G [23]
Splashed white 16 20,117,302 MITF 11bp deletion-insertion Not detected Not detected Not detected Not detected Not detected [24,25]
Splashed white 16 20,105,348 MITF DelGTGTC Not detected Not detected Not detected Not detected Not detected [24,25]
Splashed white 6 11,429,753 PAX3 C/T substitution C/C C/C C/C C/C C/C [24,25]
Lavender foal syndrome (LFS) 1 138,235,715 MYO5A 1 bp deletion: frameshift/stop Not detected Not detected Not detected Not detected Not detected [10]
Lethal white foal syndrome 17 50,624,771 EDNRB AG deletion-insertion: Ile/Lys Not detected Not detected Not detected Not detected Not detected [26]
Silver coat color, congenital eye disease 6 73,665,304 PMEL17 C/T substitution: Arg/Cys C/C C/C C/C C/C C/C [27]




















Table 4 Investigation of known variants affecting disease traits











Severe combined immunodeficiency 9 35,528,429 DNAPK 5bp deletion: stop Not detected Not detected Not detected Not detected Not detected [28]
Cerebellar abiotrophy 2 13,074,277 TOE1 G/A substitution: Arg/His G/G G/A G/G G/G G/G [15]
Glycogen branching enzyme deficiency 26 8,217,062 GBE1 C/A substitution: Tyr/stop C/C C/C C/C C/C C/C [29]
Equine hyperkalemic periodic paralysis 11 15,500,439 SCN4A C/G substitution: Phe/Leu C/C C/C C/C C/C C/C [30]
Polysaccharide storage myopathy (PSSM type 1) 10 18,940,324 GYS1 G/A substitution: Arg/His G/G G/G G/G G/G G/G [31]
Malignant hyperthermia 10 9,554,699 RYR1 C/G substitution: Arg/Gly C/C C/C C/C C/C C/C [32]
Hereditary equine regional dermal asthenia 1 128,056,748 PPIB G/A substitution: Gly/Arg G/G G/G G/G G/G G/G [33,34]
Junctional epidermolysis bullosa 8 45,603,643 LAMC2 C insertion: frameshift/stop Not detected Not detected Not detected Not detected Not detected [35,36]




















Table 5 Investigation of known variants affecting performance traits













Body size 3 105,547,002 LCORL C/T substitution T/T T/T T/T C/T C/T [16-18]
Gait
coordination
23 22,999,655 DMRT3 C/A substitution:
Ser/stop
C/C C/C C/C C/C C/C [38]
Racing
distance
18 66,493,737 MSTN C/T substitution C/T T/T C/C T/T T/T [19]
Racing
performance
4 38969307 PDK4 C/A substitution C/C A/A C/C A/C C/C [39]
Racing
performance
4 38973231 PDK4 G/A substitution A/A A/A G/G A/G A/G [39]
Racing
performance
10 15884567 CKM G/A substitution A/G G/G G/G A/G G/G [40]
Racing
performance
22 22684390 COX4I2 C/T substitution C/C C/T T/T C/T C/C [40]
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mutations could be due to false detection or might be in-
dividual mutations for the analyzed horses we suppose
that our data generally reflect the specific characteristics
of breeds and non-breeds and give an idea of what the
main developmental focus of each group is.
Methods
Ethics statement
All animal work has been conducted according to the
national and international guidelines for animal wel-
fare. The Lower Saxony state veterinary office at the
Niedersächsisches Landesamt für Verbraucherschutz und
Lebensmittelsicherheit, Oldenburg, Germany, was the re-
sponsible Institutional Animal Care and Use Committee
(IACUC) for this specific study. The EDTA-blood sampling
for the present study had been approved by the IACUC of
Lower Saxony, the state veterinary office Niedersächsisches
Landesamt für Verbraucherschutz und Lebensmittelsicherheit,
Oldenburg, Germany (registration number 11A 160/7221.3-
2.1-015/11, 8.84-02.05.20.12.066).
Animals
Genomic DNA of a Duelmener mare, a Sorraja stallion, an
Arabian stallion and two Hanoverian stallions was isolated
using 600 ul EDTA blood which was drawn from one jugu-
lar vein with a sterile Vacuette system (Greiner Bio-One,
Kremsmünster, Austria). An ethanol fraction was per-
formed by 6 M NaCl, 70% ethanol, and 100% ethanol (Carl
Roth, Karlsruhe, Germany) in consecutive steps according
to standard protocols.
Sequencing and alignment
Sequencing of the whole genome was performed using
an Illumina HiSeq2000 (Illumina, San Diego, CA). The
short-insert paired-end libraries were prepared using
Illumina DNA sample preparation kit (Illumina) followingmanufacturer’s guidelines with minor modifications. Gen-
omic DNA was quantified using Qubit 2.0 Fluorometer
(Life Technologies, Eugene, Oregon) and 2.0 micrograms
of genomic DNA were sheared on a Covaris E220 (Covaris,
Woburn, MA), size selected and concentrated using
AMPure XP beads (Agencourt, Beckman Coulter) in order
to reach the fragment size of 220-480 bp. The fragmented
DNA was end-repaired, adenylated and ligated to Illumina
specific paired-end adaptors. The quantification of all li-
braries was done using the Library Quantification Kit
(Kapa Biosystems, Woburn, MA). Four libraries were se-
quenced on one lane each and one library (Hanoverian 1)
on two lanes of HiSeq2000 flowcell v3 (Illumina) in paired
end mode (2 × 101 bp reads) using TruSeq SBS Kit v3-HS
reagents (Illumina). Sequencing was performed according
to standard Illumina operation procedures with minimal
yield of 25 Gb for each sample.
Primary data analysis was carried out with the standard
Illumina pipeline. Sequencing reads were trimmed from
the end of the read until the first base over Q10 and reads
shorter than 40 bp were discarded. The Genome Multitool
(GEM) [50] mapper was used to identify all alignments to
the reference (EquCab 2.70) with 4 or less mismatches
which included up to one insertion or deletion of up to 25
bases. To map reads with higher divergence we addition-
ally performed alignment with BFAST [51].
Variant detection
For the discovery of SNPs and indels, we applied the Gen-
ome Analysis Toolkit (GATK) version 2.7-2 [52,53]. Fur-
ther basic statistics like the total read depth for each
position, consensus quality, allele frequency and genotype
quality for the variant in one sample were computed by
SAMtools (Sequence Alignment/Map) and BCFtools from
the SAMtools package [54]. The chromosomal enrich-
ment of detected variants was accounted dividing the
number of variants by the length of the chromosome (bp)
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pair. The distribution of variants of the whole-genome was
computed dividing the total number of variants by the total
length of reference genome and used as threshold value for
significant chromosomal enrichment. All experiment files
are available at the NCBI Sequence Read Archive (http://
www.ncbi.nlm.nih.gov/sra), accession number SRP033361.
The VCF file can be downloaded at Intrepid Bioinformatics
at http://dx.doi.org/10.13013/J6MW2F2B.Comparative analyses
For comparative analysis with BeadChip data of the Arabian
and Hanoverians we genotyped 50 ng/μl DNA on the
Illumina Equine SNP50 genotyping BeadChip (Illumina)
for 54,602 SNPs using standard procedures as recom-
mended by the manufacturer. Data were analyzed and file
clusters were generated with the genotyping module ver-
sion 3.2.32 of the BeadStudio program [17] (Illumina). All
genotyped SNPs were compared to our next generation se-
quencing data using SAS/Genetics, version 9.4 (Statistical
Analysis System, Cary, NC, 2013) and complementary
bases were adjusted for comparison. In a second step we
performed SAS-analysis to identify known and novel
variants in comparison with the databases dbSNP (ftp://
ftp.ncbi.nih.gov/snp/organisms/horse_9796/chr_rpts/,
download 03.09.2009), Broad Institute (http://www.
broadinstitute.org/ftp/distribution/horse_snp_release/v2/,
download 19.09.2013), Ensembl (ftp://ftp.ensembl.org/
pub/release-73/variation/gvf/equus_caballus/ Equus_caballus.
gvf.gz, download 19.09.2013) and published data from
Orlando et al. [8] and Doan et al. [11]. A concordance
of our detected variants with these data was calculated
by the position of the variants in the genome.Functional annotation and analysis
We performed functional annotation of the detected vari-
ants using the genetic variant annotation and effect predic-
tion toolbox SNPEff [13], version 3.1 that provided lists of
expected effects, their position and involved genes affected
by these variants. The variants were categorized by their
functional class and impact. Finally, the data of calculated
effects produced in known genes were provided for further
analysis in a VCF output file. We further categorized this
data by their influence on coding or regulative regions in
breed and non-breed horses. All genes were converted to
human ortholog genes using g: Profiler [55,56] in order to
improve the identification of gene ontology terms. The
raw and Bonferroni corrected P-values for the enrichment
analysis of genes involved in biological processes were
computed using PANTHER (Protein ANalysis THrough
Evolutionary Relationships, version 8.0) classification sys-
tem [57,58]. Values for heterozygosities were defined for
all 10,193,421 sites with SNPs. In addition, we calculatedheterozygosities for regions with private variants in im-
munity related genes using SAS/Genetics.Additional files
Additional file 1: Summary of next generation sequencing data of
five horses on the Illumina HiSeq2000. The mapping metrics
(A) mean and median coverage (B) and number of shared and individual
variants (C) are shown.
Additional file 2: Total number of variants by chromosome detected
by next generation sequencing in breed and non-breed horses.
Additional file 3: Average number of variants per base pair by
chromosome (ECA) detected by next generation sequencing of five
horses. ECA12 and ECA19 show the highest number of detected variants
with regard to the chromosomal size.
Additional file 4: Comparison of non exonic SNPs and indels from
current analysis with known variants from different databases. The
total number of SNPs and indels per SNPEff term detected in five horses
and their concordance with dbSNP, Broad Institute and Ensembl data as
well as data published by Orlando et al. [8] and Doan et al. [11] are shown.
Additional file 5: Functional classification analysis of the predicted
private non-synonymous SNPs in non-breed (A) and breed (B) horses.
Both groups show a similar distribution of gene functions.
Additional file 6: Number of effects by private and shared indels
detected by next generation sequencing in five horses. The
presented results are classified by SNPEff terms for each breed.
Additional file 7: Characterization of private variations with
possibly damaging effects. Private SNPs and INDELs which are
predicted to cause a loss of stop codon, exon deletions as well as codon
changes are shown.
Additional file 8: Functional classification analysis of the predicted
codon changes possibly caused by private indels. Genes involved in
immune system processes are more frequent in breed horses (22.6%) in
comparison with non-breed horses (6.7%).
Additional file 9: Enrichment analysis of significantly overrepresented
genes involved in biological processes. The software PANTHER was used
for the evaluation of SNPs in coding regions and regulative regions for
non-breed and breed horses. Raw P-values and Bonferoni corrected significant
P-values are shown.Abbreviations
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